— Know what they know.
Not Investment Advice

IPAH OTC

Interpharm Holdings, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -99.8% 1Y: -99.8% 3Y: +0.0% 5Y: -95.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 50 · $660 mcap · 20M float · 0.0000% daily turnover

Income Trends

Revenue
$76M +19.3% ▲
5Y CAGR: +7.3%
Gross Profit
$22M +24.3% ▲
5Y CAGR: +28.1%
Operating Income
-$11M -125.3% ▼
Net Income
-$14M -270.9% ▼
EPS (Diluted)
$-0.26 -73.3% ▼
EBITDA
-$8M -153.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2001FY2003FY2004FY2005FY2006
Revenue$39M$41M$40M$63M$76M
YoY Growth-26.4%+0.0%-2.9%+58.7%+19.3%
Cost of Revenue$34M$31M$31M$46M$54M
Gross Profit$5M$10M$9M$17M$22M
Gross Margin13.9%23.8%22.7%27.5%28.7%
R&D Expenses$0$538K$4M$11M$19M
SG&A Expenses$7M$4M$5M$12M$13M
Operating Expenses$7M$5M$9M$22M$32M
Operating Income-$1M$5M-$95K-$5M-$11M
Operating Margin-3.7%12.3%-0.2%-7.5%-14.2%
Interest Expense$0$0$0$0$0
Income Before Tax-$2M$5M-$222K-$5M-$14M
Tax Expense$64K$2M-$73K-$2M$190K
Net Income-$2M$3M-$149K-$4M-$14M
Net Margin-4.3%7.6%-0.4%-6.0%-18.6%
EPS (Diluted)$-0.24$0.04$-0.01$-0.15$-0.26
EBITDA-$1M$6M$1M-$3M-$8M
Shares Outstanding7M16M26M37M65M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms